HHS awards $161M non-competitive contract to ACUMEN LLC for SAFE RX PROJECT

Contract Overview

Contract Amount: $16,147,179 ($16.1M)

Contractor: Acumen LLC

Awarding Agency: Department of Health and Human Services

Start Date: 2008-05-28

End Date: 2013-03-30

Contract Duration: 1,767 days

Daily Burn Rate: $9.1K/day

Competition Type: NON-COMPETITIVE DELIVERY ORDER

Number of Offers Received: 1

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: SAFE RX PROJECT

Place of Performance

Location: BURLINGAME, SAN MATEO County, CALIFORNIA, 94010

State: California Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $16.1 million to ACUMEN LLC for work described as: SAFE RX PROJECT Key points: 1. Significant contract value of $161.47 million. 2. Sole-source award indicates limited competition. 3. Contract duration of nearly 5 years. 4. Focus on Research and Development in Social Sciences and Humanities.

Value Assessment

Rating: questionable

The contract type is Cost Plus Fixed Fee, which can lead to cost overruns if not managed carefully. Without competitive bids, it's difficult to assess if the pricing is optimal compared to similar R&D contracts.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This was a non-competitive delivery order, meaning only one vendor was considered. This limits price discovery and potentially leads to higher costs for taxpayers.

Taxpayer Impact: The lack of competition raises concerns about whether taxpayers received the best possible value for the $161.47 million spent.

Public Impact

Taxpayers may have overpaid due to the absence of competitive bidding. The long duration of the contract could lock in potentially inefficient practices. Lack of transparency in the sole-source award process. Potential for funds to be diverted from more competitive or cost-effective solutions.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

The contract falls under Research and Development in Social Sciences and Humanities. Spending in this sector can vary widely, but large sole-source R&D contracts warrant scrutiny to ensure scientific and societal benefit justifies the cost.

Small Business Impact

The data indicates this contract was not awarded to small businesses (ss: false, sb: false).

Oversight & Accountability

The non-competitive nature of this award suggests a need for robust oversight to ensure funds are used effectively and for their intended purpose, especially given the significant value.

Related Government Programs

Risk Flags

Tags

research-and-development-in-the-social-s, department-of-health-and-human-services, ca, delivery-order, 10m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $16.1 million to ACUMEN LLC. SAFE RX PROJECT

Who is the contractor on this award?

The obligated recipient is ACUMEN LLC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Centers for Medicare and Medicaid Services).

What is the total obligated amount?

The obligated amount is $16.1 million.

What is the period of performance?

Start: 2008-05-28. End: 2013-03-30.

What specific research outcomes were achieved by ACUMEN LLC under the SAFE RX PROJECT, and did they justify the $161.47 million cost?

The provided data does not detail the specific research outcomes or deliverables of the SAFE RX PROJECT. A thorough review would require access to project reports, milestones achieved, and a cost-benefit analysis comparing the actual outcomes against the initial objectives and the significant investment of $161.47 million.

Were there any attempts to justify the sole-source award, and what risks were identified in proceeding without competition?

The data indicates a 'NON-COMPETITIVE DELIVERY ORDER' (ct: NON-COMPETITIVE DELIVERY ORDER), suggesting no formal competition. Justification for sole-source awards typically involves unique capabilities or urgent needs. Without this justification, the primary risk is paying a premium due to the lack of market price discovery and potentially receiving suboptimal solutions.

How effective was the Centers for Medicare and Medicaid Services in managing this Cost Plus Fixed Fee contract to ensure value for taxpayer money?

The effectiveness of CMS's management of this Cost Plus Fixed Fee contract is difficult to assess solely from the provided data. This contract type requires diligent oversight to control costs and ensure performance. The lack of competition and the contract's substantial value necessitate a detailed review of performance metrics, cost audits, and adherence to contract terms to gauge true effectiveness.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in the Social Sciences and Humanities

Product/Service Code: RESEARCH AND DEVELOPMENTN – Health R&D Services

Competition & Pricing

Extent Competed: NON-COMPETITIVE DELIVERY ORDER

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Offers Received: 1

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 500 AIRPORT BLVD STE 365, BURLINGAME, CA, 94010

Business Categories: Category Business, Small Business

Financial Breakdown

Contract Ceiling: $16,147,179

Exercised Options: $16,147,179

Current Obligation: $16,147,179

Contract Characteristics

Multi-Year Contract: Yes

Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED

Parent Contract

Parent Award PIID: HHSM500200600006I

IDV Type: IDC

Timeline

Start Date: 2008-05-28

Current End Date: 2013-03-30

Potential End Date: 2013-03-30 00:00:00

Last Modified: 2021-02-17

More Contracts from Acumen LLC

View all Acumen LLC federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending